Ann Rheum Dis

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaufmann, S H E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaufmann, S H E
Annals of the Rheumatic Diseases 2002;61:ii54-ii58
© 2002 by Annals of the Rheumatic Diseases


REPORT

Protection against tuberculosis: cytokines, T cells, and macrophages

S H E Kaufmann

Max-Planck-Institute for Infection Biology, Germany

Correspondence to:
Correspondence:
Professor S H E Kaufmann, Max-Planck-Institute for Infection Biology, Department of Immunology, Schumannstrasse 21-22, D-10117 Berlin, Germany;
kaufmann{at}mpiib-berlin.mpg.de


ABSTRACT
Tuberculosis remains a major health problem, with two million deaths and eight million new cases annually. At the same time, two billion people (one third of the total world population) are infected with the aetiological agent, Mycobacterium tuberculosis. Of these, fewer than 10% ever develop disease, although the pathogen is not eradicated but rather contained in discrete lesions. Hence, the immune system is highly effective in containing the pathogen, but fails to eradicate it. Disease typically develops through reactivation once the immune system is weakened. The immune response to M tuberculosis is T cell dependent. It comprises not only the conventional CD4 and CD8 T cells, but also {gamma}{delta} T cells and CD1 restricted T cells. {gamma}{delta} T cells recognise phospholigands and no presentation molecules are known thus far. CD1 restricted T cells recognise glycolipids, which are highly abundant components of the mycobacterial cell wall. Although different T cells are required for optimum protection, the immune mechanisms known to have a role in acquired resistance can be associated with two major mechanisms: (a) activation of macrophages by cytokines; (b) direct cytolytic activity. In vivo granuloma formation, which is central to protection, is induced and sustained by cytokines. Mycobacteria are contained within granulomas and in this way are prevented from spreading all over the body.


Keywords: tuberculosis; cytokines; T cells; macrophages

Abbreviations: HIV, human immunodeficiency virus; IFN{gamma}, interferon {gamma}; LT{alpha}, lymphotoxin {alpha}; MDR, multidrug resistant; MHC, major histocompatibility complex; TNF{alpha}, tumour necrosis factor {alpha}




This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
Y. J. Jeong and K. S. Lee
Pulmonary Tuberculosis: Up-to-Date Imaging and Management
Am. J. Roentgenol., September 1, 2008; 191(3): 834 - 844.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
R. Phillips, C. Horsfield, J. Mangan, K. Laing, S. Etuaful, P. Awuah, K. Nyarko, F. Osei-Sarpong, P. Butcher, S. Lucas, et al.
Cytokine mRNA Expression in Mycobacteriam ulcerans-Infected Human Skin and Correlation with Local Inflammatory Response.
Infect. Immun., May 1, 2006; 74(5): 2917 - 2924.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
R. Phillips, C. Horsfield, S. Kuijper, S. F. Sarfo, J. Obeng-Baah, S. Etuaful, B. Nyamekye, P. Awuah, K. M. Nyarko, F. Osei-Sarpong, et al.
Cytokine Response to Antigen Stimulation of Whole Blood from Patients with Mycobacterium ulcerans Disease Compared to That from Patients with Tuberculosis
Clin. Vaccine Immunol., February 1, 2006; 13(2): 253 - 257.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. A. Tree, M. J. Elmore, S. Javed, A. Williams, and P. D. Marsh
Development of a Guinea Pig Immune Response-Related Microarray and Its Use To Define the Host Response following Mycobacterium bovis BCG Vaccination
Infect. Immun., February 1, 2006; 74(2): 1436 - 1441.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Sakthianandeswaren, C. M. Elso, K. Simpson, J. M. Curtis, B. Kumar, T. P. Speed, E. Handman, and S. J. Foote
The wound repair response controls outcome to cutaneous leishmaniasis
PNAS, October 25, 2005; 102(43): 15551 - 15556.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
E. A. Roberts, A. Clark, S. McBeth, and R. L. Friedman
Molecular Characterization of the eis Promoter of Mycobacterium tuberculosis
J. Bacteriol., August 15, 2004; 186(16): 5410 - 5417.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. L. Fuller, J. L. Flynn, and T. A. Reinhart
In Situ Study of Abundant Expression of Proinflammatory Chemokines and Cytokines in Pulmonary Granulomas That Develop in Cynomolgus Macaques Experimentally Infected with Mycobacterium tuberculosis
Infect. Immun., December 1, 2003; 71(12): 7023 - 7034.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2002 BMJ Publishing Group Ltd & European League Against Rheumatism